Atopic Eczema Community

Atopic dermatitis (AD), also called atopic eczema, is a common chronic or recurrent inflammatory skin disease and affects 15-20% of children and 1-3% of adults worldwide.  Patient organizations that serve people living with Atopic Eczema, provide essential services, support, access to information, opportunities to link with other patients and speak up for access to care and treatment. This is a disease where patient organizations are currently under-resourced and not well connected to each other. 

GlobalSkin began working with this global community of leaders to significantly and measurably improve capacity building and coordination of a synchronized strategic approach to improve access to care, critical information, and treatment options for patients. 

On September 14, we were proud to once again lead the World Atopic Eczema Day 2025 campaign under the powerful theme: “Our Skin, Our Journey.” This year’s theme spotlighted the evolving lived experiences of people with atopic eczema — the daily challenges they face, the progression of the disease over time, and their collective journey toward better care and understanding. 

We extend our heartfelt thanks to everyone who joined the #AtopicEczemaJourney campaign. Thanks to the collective efforts of patients, advocacy organizations, healthcare professionals, and industry partners, we helped elevate global awareness and highlight the realities of living with atopic eczema. 
 
This years' toolkit was filled with new practical resources, ideas, and inspiration to help organizations plan meaningful activities and raise awareness in their communities. This guide is designed annually to make  efforts more impactful and easier to execute. 

Check out the World Atopic Eczema Day Report HERE where we showcases our very successful awareness day campaign, World Atopic Eczema Day Fund and we share some fantastic Member Success Stories.

At the 2025 Atopic Eczema Forum, 51 participants came together to explore how policy can drive change for those living with atopic eczema. This event was co-hosted with GAAPP, and expertly facilitated by Neil Bertelsen. 

Through thoughtful reflection and discussions, attendees identified their organization’s advocacy goals, mapped realistic progress to 2030, and discussed how the global community—through GlobalSkin and GAAPP—can provide the tools and support needed to succeed. The forum concluded with Members leaving with a five-year policy roadmap, concrete advocacy initiatives and renewed momentum for policy action worldwide, as patient leaders and the Atopic Eczema Community.